Jm. Michael-robinson et al., Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status, GUT, 48(3), 2001, pp. 360-366
Background-The presence of high level DNA microsatellite instability (MSI-H
) in colorectal cancer is associated with an improved prognosis, as is the
presence of tumour infiltrating lymphocytes (TILs). It is not clear if TILs
contribute directly to the survival advantage associated with MSI-H cancer
s through activation of an antitumour immune response.
Aims-To correlate TIL and apoptosis rates in colorectal cancer stratified b
y MSI status.
Methods-The distribution of TILs was characterised and quantified in a sele
cted series of 102 sporadic colorectal cancers classified according to leve
ls of MSI as 32 MSI-H, 30 MSI-low (MSI-L), and 40 microsatellite stable (MS
S). Archival blocks were immunostained using the T cell markers CD3 and CD8
, and the B cell marker CD20. Apoptosis of malignant epithelial cells was q
uantified by immunohistochemistry with the M30 CytoDEATH antibody.
Results-Positive staining with anti-CD3 and negative staining with anti-CD2
0 identified virtually all TILs as T cells. The majority of CD3(+) TILs (>7
5%) also stained with anti-CDS. TILs were most abundant in MSI-H colorectal
cancers in which 23/32 (72%) scored as TIL positive. Only 5/40 (12.5%) MSS
tumours and 9/30 (30%) MSI-L cancers were TIL positive (p<0.0001). MSI-H c
ancers showed a twofold higher rate of apoptosis (mean (SD) 3.52 (0.34)%) t
han the MSS cancers (1.53 (0.23)%) while the MSI-L subgroup had an intermed
iate level (2.52 (0.35)%) (p<0.0001). Overall, there was a small (r=0.347)
but significant linear correlation between CD3(+) and M30(+) random apoptos
is counts (p<0.001). However, TILs and apoptosis showed little colocalisati
on.
Conclusions-While TILs might be expected to explain the increased apoptotic
rate and improved prognosis of MSI-H cancers, it is likely that TILs and a
poptosis are independent characteristics of MSI-H cancers.